Vimarsana
Biggest News Aggregation in the World

Page 30 - Abt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Abt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Abt Today - Breaking & Trending Today

Arcblock (ABT) Price Down 22.7% Over Last Week - Vimarsana News

Arcblock (ABT) Price Down 22.7% Over Last Week

Arcblock (ABT) traded down 2.7% against the dollar during the twenty-four hour period ending at 23:00 PM ET on April 18th. In the last seven days, Arcblock has traded 22.7% lower against the dollar. One Arcblock token can now be purchased for approximately $2.06 or 0.00003421 BTC on cryptocurrency exchanges. Arcblock has a total market […]

Abbott Laboratories (NYSE:ABT) Shares Sold by Guardian Investment Management - Vimarsana News

Abbott Laboratories (NYSE:ABT) Shares Sold by Guardian Investment Management

Guardian Investment Management lessened its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 1.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 12,750 shares of the healthcare product maker’s stock after selling 200 shares during the quarter. […]

Abbott Laboratories (NYSE:ABT) Posts Quarterly Earnings Results, Beats Estimates By $0.02 EPS - Vimarsana News

Abbott Laboratories (NYSE:ABT) Posts Quarterly Earnings Results, Beats Estimates By $0.02 EPS

Abbott Laboratories (NYSE:ABT – Get Free Report) released its quarterly earnings data on Wednesday. The healthcare product maker reported $0.98 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.96 by $0.02, RTT News reports. Abbott Laboratories had a return on equity of 20.65% and a net margin of 14.27%. The company […]

Source: wkrb13.com
Abbott Laboratories (NYSE:ABT) Updates Q2 2024 Earnings Guidance - Vimarsana News

Abbott Laboratories (NYSE:ABT) Updates Q2 2024 Earnings Guidance

Abbott Laboratories (NYSE:ABT – Get Free Report) issued an update on its second quarter 2024 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 1.080-1.120 for the period, compared to the consensus earnings per share estimate of 1.120. The company issued revenue guidance of -. Abbott Laboratories also updated its FY […]

Abbott Laboratories (NYSE:ABT) Updates FY24 Earnings Guidance - Vimarsana News

Abbott Laboratories (NYSE:ABT) Updates FY24 Earnings Guidance

Abbott Laboratories (NYSE:ABT – Get Free Report) updated its FY24 earnings guidance on Wednesday. The company provided earnings per share guidance of $4.55-4.70 for the period, compared to the consensus earnings per share estimate of $4.62. Abbott Laboratories also updated its FY 2024 guidance to 4.550-4.700 EPS. Analyst Ratings Changes Several brokerages have issued reports […]